← Leaderboards
Wei-Zen Wei
Wayne State University
$6,644,720
Attributed
$6,828,942
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $544.3K · FY2005–20$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$6,828,942 · 3
By mechanism
R01$6,460,497 · 2
R21$368,445 · 1
Top collaborators
- Nerissa Therese Viola2 shared
Most similar at Wayne State University
Same institution · by research overlap
- Nerissa Therese Viola$2,971,490
Others in their field
Top investigators on “Tumor Immunity”
- Timothy J Eberlein · Washington University$58,789,053
- Alan F Horwitz · University Of Virginia Charlottesville$39,846,480
- Thomas J. Kipps · University Of California San Diego$39,510,043
- Robert H Vonderheide · University Of Pennsylvania$38,155,944
- Ralph Parchment · Leidos Biomedical Research, Inc.$30,925,921
- John H Sampson · Duke University$30,713,439
Research focus
Tumor ImmunityImmuneTumorVaccinationAntigensImmunogenicityCancer ImmunotherapyIn SituTumor AntigensCancer VaccinesImmunoregulationPreventReportingDna VaccinesT-LymphocyteRegimenGenesImmunityBreast Cancer VaccineNeoplastic CellMalignant NeoplasmsImmune ResponseRattusVaccines
Grant awards (29)
Development of Breast Cancer Vaccines$308,000
R01 · FY2020 · CA · contact PI
Development of Breast Cancer Vaccines$298,760
R01 · FY2019 · CA · contact PI
Development of Breast Cancer Vaccines$308,000
R01 · FY2018 · CA · contact PI
Directing Cancer Immunotherapy with Real-Time ImmunoPET$167,475
R21 · FY2018 · CA · contact PI
Development of Breast Cancer Vaccines$308,000
R01 · FY2017 · CA · contact PI
Directing Cancer Immunotherapy with Real-Time ImmunoPET$200,970
R21 · FY2017 · CA · contact PI
Development of Breast Cancer Vaccines$307,000
R01 · FY2016 · CA · contact PI
Development of Breast Cancer Vaccines$274,090
R01 · FY2015 · CA · contact PI
Development of Breast Cancer Vaccines$1
R01 · FY2014 · CA · contact PI
Development of Breast Cancer Vaccines$286,273
R01 · FY2013 · CA · contact PI
Development of Breast Cancer Vaccines$304,546
R01 · FY2012 · CA · contact PI
Development of Breast Cancer Vaccines$304,546
R01 · FY2011 · CA · contact PI
Tilting the balance in cancer immunotherapy and autoimmunity$259,391
R01 · FY2010 · CA · contact PI
Development of Breast Cancer Vaccines$139,541
R01 · FY2010 · CA · contact PI
Tilting the balance in cancer immunotherapy and autoimmunity$259,391
R01 · FY2009 · CA · contact PI
Tilting the balance in cancer immunotherapy and autoimmunity$259,391
R01 · FY2008 · CA · contact PI
Development of ERBB2 Based Breast Cancer Vaccines$269,170
R01 · FY2007 · CA · contact PI
Tilting the balance in cancer immunotherapy and autoimmunity$259,391
R01 · FY2007 · CA · contact PI
Development of ERBB2 Based Breast Cancer Vaccines$277,209
R01 · FY2006 · CA · contact PI
Tilting the balance in cancer immunotherapy and autoimmunity$267,138
R01 · FY2006 · CA · contact PI
Development of ERBB2 Based Breast Cancer Vaccines$283,880
R01 · FY2005 · CA
Development of ERBB2 Based Breast Cancer Vaccines$283,880
R01 · FY2004 · CA
Development of ERBB2 Based Breast Cancer Vaccines$283,880
R01 · FY2003 · CA
DEVELOPMENT OF ERBB2 BASED BREAST CANCER VACCINES$245,942
R01 · FY2002 · CA
DEVELOPMENT OF ERBB2 BASED BREAST CANCER VACCINES$68,540
R01 · FY2002 · CA
DEVELOPMENT OF ERBB2 BASED BREAST CANCER VACCINES$239,079
R01 · FY2001 · CA
DEVELOPMENT OF ERBB2 BASED BREAST CANCER VACCINES$67,370
R01 · FY2001 · CA
DEVELOPMENT OF ERBB2 BASED BREAST CANCER VACCINES$232,418
R01 · FY2000 · CA
DEVELOPMENT OF ERBB2 BASED BREAST CANCER VACCINES$65,670
R01 · FY2000 · CA